Human T cell leukemia virus type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers

Journal of Infectious Diseases

Volumn 183, Issue 6, 2001, Pages 857-864

  Ureta Vidal, Abel ^a   Pique, Claudine ^d   Garcia, Zacarias ^a   Dehée, Axelle ^e   Tortevoye, Patricia ^b   Désiré, Nathalie ^e   Gessain, Antoine ^c   Chancerel, Bruno ^g   Gout, Olivier ^f   Lemonnier, François A ^a   Cochet, Madeleine ^a  

^a Unité d Immunité Cellulaire Antivirale   (United States)

^b Laboratoire de Génétique de la Prédisposition aux Maladies Infectieuses   (United States)

^c Institut Pasteur   (United States)

^d UPR 9051 Hôpital   (United States)

^e HÔPITAL ROTHSCHILD   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g Etablissement de Transfusion Sanguine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; T LYMPHOCYTE RECEPTOR; TAX PROTEIN;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; STATISTICAL ANALYSIS; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION;

ADULT; AGE FACTORS; CARRIER STATE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; GENE PRODUCTS, TAX; HTLV-I ANTIBODIES; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PARAPARESIS, TROPICAL SPASTIC; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD;

EID: 0035869206     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/319264     Document Type: Article

References (51)

1. Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera
2. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease
3. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis
4. HTLV-I associated myelopathy, a new clinical entity
5. HTLV-I-associated myelopathy: Clinicopathologic correlation with localization of provirus to spinal cord
6. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): A chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system
7. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: High proviral load strongly predisposes to HAM/TSP
8. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy
9. High human T cell lymphotropic virus type I (HTLV-I)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-I-associated neurological disease
10. + T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients
11. Chronic progressive myelopathy associated with HTLV-I: Oligoclonal IgG and anti-HTLV-I IgG antibodies in cerebrospinal fluid and serum
12. Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis
13. + T lymphocytes
14. Perivascular T cells are infected with HTLV-I in the spinal cord lesions with HTLV-I associated myelopathy/tropical spastic paraparesis: Double staining of immunohistochemistry and polymerase chain reaction in situ hybridization
15. Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease
16. + CTLs clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase
17. Pathogenesis of chronic progressive myelopathy associated with human T-cell lymphotropic virus type I
18. Altered subsets of peripheral blood lymphocytes in patients with HTLV-I associated myelopathy (HAM)
19. Immunologic correlates of spontaneous lymphocyte proliferation in human T-lymphotropic virus infection
20. T-cell clonality in immune responses
21. Accumulation of human T lymphotropic virus HTLV-I-specific T cell clones in HTLV-I-associated myelopathy/tropical spastic paraparesis patients
22. + T cell subsets in human T lymphotropic virus type I infected individuals
23. T-cell repertoires in healthy and diseased human tissues analysed by T-cell receptor beta-chain CDR3 size determination: Evidence for oligoclonal expansions in turnouts and inflammatory diseases
24. Spread of clonal T-cell expansions in rheumatoid arthritis patients
25. + repertoire during antiviral therapy
26. Real time quantitative PCR
27. TaqMan PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK4 locus haploinsufficiency
28. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
29. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments
30. Implication of γδ T cells in the human immune response to cytomegalovirus
31. Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from Cytotoxic T lymphocytes directed against viral peptides
32. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously
33. High activated and memory cytotoxic T-cell responses to HTLV-I in healthy carriers and patients with tropical spastic paraparesis
34. Correlation between viral DNA load and serum anti p19 antibody concentration in symptomless human T-lymphotropic virus type-I (HTLV-I)-infected individuals
35. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection
36. + cytotoxic T lymphocytes from patients with HTLV-I-associated disease: Evidence for oligoclonal expansion
37. + T cells in health and disease: Aging, infection, or immune regulation?
38. + T cell clones in elderly humans
39. + subsets
40. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy
41. Proliferation of HTLV-I infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM
42. Increases in helper inducer T cells and activated T cells in HTLV-I-associated myelopathy
43. + suppressor inducer subset in patients infected with human F cell lymphotropic virus types I or II
44. T-cell activation by autologous human T-cell leukemia vitro, type I-infected T-cell clones
45. HTLV-I-induced T-cell activation
46. CDR3-independent gamma delta V delta 1 + T cell expansion in the peripheral blood of HIV-infected persons
47. + T cells with soluble HLA-A2/Tax1 1-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy
48. Activated, HTLV-I-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis
49. + T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes
50. Detection of human T-lymphotropic virus type I p40 tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis